Probing cytochrome P450-mediated activation with a truncated azinomycin analogue

Vinader, Victoria, Sadiq, Maria, Sutherland, Mark, Huang, Menying, Loadman, Paul, Elsalem, Lina, Shnyder, Steven, Cui, Hongjuan, Afarinkia, Kamyar, Searcey, Mark ORCID: https://orcid.org/0000-0003-2273-8949, Patterson, Laurence and Pors, Klaus (2015) Probing cytochrome P450-mediated activation with a truncated azinomycin analogue. MedChemComm, 6. pp. 187-191. ISSN 2040-2511

Preview

PDF (Med chem comm 2014) - Accepted Version Download (966kB) | Preview

Abstract

A deactivated alkene precursor (IC50 = 81 μM) to the azinomycin epoxide natural product can be bioactivated by several cytochromes P450 (CYP) to generate antiproliferative metabolites with increased potency (IC50 = 1-30 μM) in CHOwt cells. CYP1A1 and 3A4 were shown to generate exclusively the unnatural and the natural-configured azinomycin epoxide diastereoisomer respectively, while CYP1B1 produced both epoxides in a 3:1 mixture. The antiproliferative activity is linked to DNA damage as demonstrated using the comet assay.

Item Type:	Article
Uncontrolled Keywords:	prodrug ,azinomycin,cytochrome p-450 cyp1a1
Faculty \ School:	Faculty of Science > School of Pharmacy (former - to 2024)
UEA Research Groups:	Faculty of Science > Research Groups > Medicinal Chemistry (former - to 2017) Faculty of Science > Research Groups > Chemical Biology and Medicinal Chemistry (former - to 2021)
Depositing User:	Pure Connector
Date Deposited:	17 Apr 2015 14:04
Last Modified:	02 Dec 2024 01:21
URI:	https://ueaeprints.uea.ac.uk/id/eprint/53175
DOI:	10.1039/C4MD00411F

Downloads

Actions (login required)

View Item